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Abstract. 
 
Herpes simplex virus 1 fuses with the plasma 
membrane of a host cell, and the incoming capsids are 
efficiently and rapidly transported across the cytosol to 
the nuclear pore complexes, where the viral DNA ge-
nomes are released into the nucleoplasm. Using bio-
chemical assays, immunofluorescence, and immuno-
electron microscopy in the presence and absence of 
microtubule depolymerizing agents, it was shown that 
the cytosolic capsid transport in Vero cells was medi-
ated by microtubules. Antibody labeling revealed the 
attachment of dynein, a minus end–directed, microtu-
bule-dependent motor, to the viral capsids. We propose 
that the incoming capsids bind to microtubules and use 
dynein to propel them from the cell periphery to the 
nucleus.
 
T
 
he
 
 entry of animal viruses into their host cells in-
volves adsorption to cell surface receptors, penetra-
tion into the cytosol, and uncoating of the viral ge-
nome. For viruses that replicate in the nucleus, entry also
entails extensive movement of viruses and viral capsids
through the cytoplasm. Transport over long distances is
particularly critical for viruses that infect neurons in which
the site of entry can be located far from the cell body and
the nucleus.
Since movement of virus-sized particles through the cy-
tosol is not likely to occur by free diffusion due to high vis-
cosity and steric obstacles (Bray, 1992; Luby-Phelps, 1994),
viruses most likely exploit the cell’s motile functions for
transport. The limited information available suggests that
viruses can make use of both microtubules (MT)
 
1
 
 and ac-
tin filaments. EM analysis has shown MT binding of cer-
tain viral capsids, such as adenovirus and reovirus in vivo
and in vitro (for review see Luftig, 1982) as well as herpes
simplex virus 1 (HSV-1) in neurons (Lycke et al., 1984, 1988;
Penfold et al., 1994)
 
.
 
 Way and co-workers have described
actin filament–dependent intra- and intercellular transport
of vaccinia virus during egress from cells (Cudmore et al.,
1995). Moreover, many viruses take advantage of the ret-
rograde movement of endocytic organelles during entry.
They are internalized by receptor-mediated endocytosis
and carried within coated vesicles and endosomes from
the cell periphery toward the perinuclear area of the cell
(see Greber et al., 1994; Marsh and Helenius, 1989).
In this study we have focused on the intracytosolic trans-
port of incoming HSV-1 capsids in Vero cells. HSV-1 has
three structural components: capsid, tegument, and enve-
lope. The capsid consists of the viral DNA of 152 kbp and
a proteinaceous shell comprising six different proteins; it
has a diameter of 125 nm, and the proteins are arranged in
an icosahedron formed by 12 pentons and 150 hexons
(Booy et al., 1991; Cohen et al., 1980; Heine et al., 1974;
Spear and Roizman, 1972). VP5 constitutes the major pro-
tein component of both hexons and pentons (Newcomb
et al., 1992; Trus et al., 1992). The tegument is a protein
layer between the envelope and the capsid and contains
 
z
 
12 different viral polypeptides (Roizman and Furlong,
1974; Roizman and Sears, 1996). While the functions of
most of these remain to be identified, one is a protein ki-
nase (LeMaster and Roizman, 1980), one induces shut off
of host cell protein synthesis (Read and Frenkel, 1983),
and some are known to be activators and modulators of vi-
ral gene expression (Batterson and Roizman, 1983; Camp-
bell et al., 1984; McLean et al., 1990). The viral envelope
contains at least 12 different membrane proteins, some of
which are involved in receptor binding and fusion.
The infectious cycle begins with virus binding to hepa-
ran sulfate receptors on the cell surface followed by glyco-
protein-mediated fusion of the envelope with the plasma
membrane (for review see Spear, 1993). After release into
the cytosol and dissociation from some of the tegument
components, the capsids move through the cytosol to the
nucleus and bind to nuclear pores (Batterson et al., 1983;
Lycke et al., 1988), whereafter the genome is released into
the nucleus. Transcription, replication of viral DNA, and
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assembly of progeny capsids take place within the host nu-
cleus (for review see Roizman and Sears, 1996; Steven and
Spear, 1996). The synthesis of early viral proteins peaks af-
ter 4–6 h of virus entry, and the first progeny viruses are
produced after 8 h (Honess and Roizman, 1973).
We analyzed the transport of incoming HSV-1 capsids
to the nucleus in fibroblasts and found that it occurs rap-
idly and efficiently by an MT-mediated mechanism. The
incoming capsids shed most of the associated tegument
proteins and bind dynein, an MT-dependent, minus end–
directed motor in the peripheral cytosol, whereafter they
are transported along MT toward the cell center. The viral
capsids thus make use of the machinery responsible for
retrograde organelle transport in animal cells.
 
Materials and Methods
 
Cells and Antibodies
 
BHK-21 cells were grown in Glasgow’s MEM with 5% FCS and 10% tryp-
tose phosphate broth, and Vero cells were grown in MEM with 7.5% FCS
and nonessential amino acids. Both media contained 100 U/ml penicillin,
100 
 
m
 
g/ml streptomycin, and 2 mM glutamine. All tissue-culture reagents
were obtained from GIBCO BRL (Gaithersburg, MD). Both cell lines
were maintained as adherent cultures in a 5% CO
 
2
 
 humid incubator at
37
 
8
 
C and passaged twice a week. We used rabbit polyclonal antibodies
against VP-5 (NC-1), VP-19c (NC-2), DNA-containing capsids (anti-HC),
empty capsids (anti-LC; all provided by Roselyn Eisenberg and Gary Co-
hen, University of Pennsylvania, Philadelphia), and a mouse mAb 8F5 against
VP5 (provided by William Newcomb and Jay Brown, University of Vir-
ginia, Charlottesville). All rabbit polyclonal antibodies to viral proteins
were preadsorbed against paraformaldehyde (PFA)–fixed, Triton X-100
(TX-100)–permeabilized Vero cells. They were used at the highest possi-
ble concentration, giving no signal in noninfected cells. An mAb against
ICP4, an early herpes protein, was obtained from Advanced Biotechnolo-
gies, Inc. (Columbia, MD). We used a mouse monoclonal anti-tubulin
(1A2; provided by Dr. Thomas Kreis, University of Geneva, Switzerland;
Kreis, 1987), a rabbit antipeptide anti–calnexin (Hammond and Helenius,
1994), and a rabbit polyclonal, affinity-purified antibody directed against a
bacterially expressed fragment of dynein heavy chain (provided by Dr.
Eugeni Vaisberg, University of Colorado at Boulder; Vaisberg et al.,
1993). Fluorescently labeled secondary antibodies (Texas red– or fluores-
cein-conjugated goat anti–rabbit or goat anti–mouse) were obtained from
Jackson ImmunoResearch Laboratories (West Grove, PA), and rabbit
anti-mouse was obtained from Organon Teknika-Cappel (Durham, NC).
 
Virological Techniques
 
Preparation of Stock Virus. 
 
HSV-1, (strain F), designated passage 1, was
obtained from American Type Culture Collection (Rockville, MD).
BHK-21 cells grown to confluency at 37
 
8
 
C for 3 d were infected with an 8
ml/175 cm
 
2
 
 flask of MEM containing 0.2% (wt/vol) BSA and 
 
,
 
0.01
plaque-forming units (PFU) per cell. After 2 h, 25 ml per flask of normal
medium was added to the cells, and after 3 d, the medium containing se-
creted extracellular virus was collected. All the following steps were per-
formed at 4
 
8
 
C. Cells and debris were removed by spinning at 2,000 rpm for
10 min, and the virus was collected by centrifugation from the medium us-
ing a JA-14 rotor (Beckman Instruments, Inc.. Palo Alto, CA) at 12,000
rpm for 90 min. The resulting pellets were resuspended by gentle shaking
overnight in MNT buffer (30 mM MES, 100 mM NaCl, 20 mM Tris, pH
7.4). After waterbath sonification (4
 
8
 
C; three times for 30 s each), the sus-
pension derived from 30 flasks was layered on top of one linear 10–40%
(wt/vol) sucrose gradient in MNT buffer and centrifuged in a Beckman
SW28 at 15,000 rpm for 45 min. The virus-containing band in the middle
of the gradient was detected by light scattering, collected (
 
z
 
3 ml per gra-
dient), aliquoted, snap frozen in liquid nitrogen, and stored at 
 
2
 
80
 
8
 
C. All
experiments described here were carried out with gradient-purified virus
from passage three. 
 
Plaque Assay. 
 
Virus was diluted in 10-fold steps into MEM with 0.2%
BSA and incubated in 24-well dishes with just confluent Vero cells for 1–2 h
at 37
 
8
 
C in a humidified 5% CO
 
2
 
 incubator. Unbound virus was removed
by three washes in MEM-BSA, and the cells were further incubated in
 
normal medium for 30 h. Plaques were counted using a dissecting micro-
scope after fixation in absolute methanol (
 
2
 
20
 
8
 
C) and Giemsa staining.
Titers of 10
 
9
 
–10
 
10
 
 PFU/ml and protein concentrations of 0.5–2 mg/ml were
obtained using this protocol. 
 
Preparation of [
 
3
 
H]Thymidine-labeled virus. 
 
BHK cells grown in an 850-
cm
 
2
 
 roller bottle to 
 
z
 
70% confluency were infected with a multiplicity of
infection (MOI) of 0.1 PFU per cell in MEM-BSA (0.2% wt/vol) contain-
ing 20 mM Hepes, pH 7.4. At 2 h postinfection (PI), the inoculum was re-
moved and normal growth medium containing 5 mCi [methyl-
 
3
 
H]thymi-
dine (Amersham Lifescience, Amersham, UK) was added. After 2 d, the
cells and the medium were collected and transferred to 4
 
8
 
C, the cells were
pelleted by a low speed spin, and the resulting supernatant was spun in a
Beckman SW40Ti at 13,700 rpm for 2 h. The pellet was resuspended by
gentle shaking overnight in MNT buffer, layered onto a linear 10–40%
(wt/vol) sucrose gradient in MNT buffer, and spun in a Beckman SW40Ti
at 15,800 rpm for 1 h. The gradient was fractionated into 1-ml fractions,
and the radioactivity in each fraction was determined by scintillation
counting. The peak fractions were pooled, aliquoted, snap frozen, and
stored at 
 
2
 
80
 
8
 
C. This preparation had a titer of 1 
 
3
 
 10
 
7
 
 PFU/ml and con-
tained 0.1 mg/ml protein.
 
Infection and Drug Treatments. 
 
Cells were inoculated with virus for 2 h
at 4
 
8
 
C with constant rocking in RPMI medium containing 0.2% (wt/vol)
BSA, 20 mM Hepes, pH 6.8, to allow virus binding. Viral infection was ini-
tiated by shifting the cells to growth medium and 37
 
8
 
C in a humidified 5%
CO
 
2
 
 incubator. In those experiments analyzing incoming viral particles,
0.5 mM cycloheximide was added to the medium to prevent synthesis of
new viral proteins and progeny virus. In some experiments, the cells were
incubated for 1 h before infection in normal medium containing 2 
 
m
 
M no-
codazole, 10 
 
m
 
M vinblastine, 2 
 
m
 
M colchicine, 20 
 
m
 
M taxol, or 0.5 
 
m
 
M cy-
tochalasin D and were maintained in these drugs during the infection. No-
codazole was stored as a stock at 20 mM, vinblastine at 10 mM, colchicine
at 20 mM, taxol at 20 mM, and cytochalasin D at 10 mM, all in DMSO and
at 
 
2
 
20
 
8
 
C.
 
Electron Microscopy
 
Vero cells grown on culture dishes or glass coverslips (for flat embedding)
for 1 d to just confluency were infected with HSV-1 at an MOI of 500 PFU
per cell (or 150 PFU/cell for the nocodazole experiment) in the presence
of cycloheximide. The virus was dialyzed before infection against RPMI
containing 0.2% BSA for 2 h (75 kD cut off) to remove sucrose. The in-
fected cells were analyzed by three different protocols.
 
Conventional Epon Embedding. 
 
The cells were fixed with 1% glutaral-
dehyde (GA) in 200 mM cacodylate, pH 7.4, or with 2% GA in PBS con-
taining 0.5 mM CaCl
 
2
 
 and 1 mM MgCl
 
2
 
 for 30 min at room temperature
(for MT analysis), treated with 1% OsO
 
4
 
 for 1 h (or 30 min for MT),
treated with 2% uranyl acetate in 50 mM maleate buffer, pH 5.2, for 1 h,
dehydrated using a graded ethanol series and propylenoxid, and pelleted
before embedding in Epon and cutting, or flat-embedded in Epon and cut
parallel to the substrate (for MT).
 
Flat Embedding of Extracted, Immunolabeled Cells. 
 
Cells were extracted
with 0.5% Triton X-100 in MT stabilizing buffer (MT buffer: 80 mM
Pipes-KOH, pH 6.8, 5 mM EDTA, 1 mM MgSO
 
4
 
, 10 
 
m
 
M taxol) for 2 min
at 37
 
8
 
C (or 4
 
8
 
C for the 0-min time point) before the addition of twofold
fixative (2% GA in MT buffer; Baas and Ahmad, 1992). The cells were
fixed for 20 min at room temperature and rinsed with PBS, and remaining
fixative was inactivated by three rounds of freshly prepared 2 mg/ml so-
dium borohydride in PBS, pH 7.4, for 15 min. After blocking with 10%
FCS in PBS, the cells were incubated with primary antibody, with second-
ary rabbit anti–mouse antibody (if the primary was not a rabbit antibody),
and with 9 nm protein A–gold (University of Utrecht, The Netherlands),
each in 10% FCS in PBS for 30 min at room temperature with extensive
washings with PBS in between. After a second fixation in 1% GA with
2 mg/ml tannic acid in 100 mM cacodylate buffer, pH 7.4, for 10 min, the
cells were contrasted using 2% OsO
 
4
 
 for 10 min and 2% uranyl acetate in
50 mM maleate buffer, pH 5.2, for 1 h. They were embedded in Epon and
ultrathin sections parallel to the substrate were prepared. All Epon sec-
tions (first and second protocols) were further contrasted using lead citrate
and uranyl acetate.
 
Frozen Hydrated Cryosections. 
 
The cells were transferred to 4
 
8
 
C and re-
moved from the culture dish either by proteinase K treatment (25 
 
m
 
g/ml
for 2–3 min on ice) and fixed (4% paraformaldehyde and 0.1% GA in 250
mM Hepes, pH 7.4), or fixed first for 20 min and then collected by scrap-
ing. After pelleting, the cells were fixed further overnight. The pellets
were infiltrated with 20% (wt/vol) polyvinyl pyrolidone and 2.0 M sucrose
in PBS and frozen in liquid nitrogen, and ultrathin sections were cut at 
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2
 
100
 
8
 
 to 
 
2
 
120
 
8
 
C and immunolabeled as previously described (Griffiths,
1993
 
a
 
; Sodeik et al., 1992).
 
Quantitation. 
 
To analyze the efficiency of capsid transport to the nu-
cleus (see Fig. 5), 25 EM negatives of infected, flat-embedded cells were
taken at a magnification of 5,800 in a systematic random fashion for each
time point (Griffiths, 1993
 
b
 
). The negatives were analyzed under a dissecting
microscope, and the number and localization of cytosolic capsids was
determined. Capsids within 100 nm of the plasma membrane were scored
as being at the plasma membrane, and within 50 nm as being on MT and
at the nuclear pore complex. The remaining capsids were scored as being
apparently free in the cytosol. Virions present in endosomes were also
counted. To quantify the effect of nocodazole (see Fig. 7), 50 negatives of
conventionally embedded cells infected in the presence or absence of no-
codazole (10 
 
m
 
M) were taken in a systematic random fashion. Cytosolic
capsids were scored as being at the plasma membrane, in the cytosol, or at
the nuclear pore complex. To quantify the dynein labeling, 25 micro-
graphs of cryosections were taken at a magnification of 16,900. Since in-
coming herpes capsids were rare structures, the specimen was systemati-
cally translated in a defined direction, and a micrograph was taken every
time a cytosolic capsid came into view. These were printed (
 
3
 
 2.7) and the
area of each structure was outlined (virions, capsids, mitochondria, nuclei,
and cytoplasm). A lattice grid was placed over the prints, and the number
of points and gold particles falling into each structure was counted. The
formula G/P*d
 
2
 
 gives the labeling density (gold particles per 
 
m
 
m
 
2
 
), where
G is the number of gold particles, P is the number of points of the lattice
grid over the structure, and d is the distance between points (Griffiths,
1993
 
b
 
).
 
Quantitation of Virus Binding and Internalization
 
We assayed for virus binding and internalization as described previously
(Helenius et al., 1980). To quantify binding, 6-well dishes containing Vero
cells grown for 2 d to just confluency were set on a metal plate on an ice
box and washed three times with ice cold RPMI-BSA, and [
 
3
 
H]thymidine-
labeled virus was added (1 ml per dish). After incubation on ice for vari-
ous amounts of time and intensive washings, the cells were scraped into 1 ml
RPMI-BSA and pelleted, and cell-associated radioactivity was determined
by scintillation counting. The data are expressed as mean values from du-
plicates. To assay for virus internalization, [
 
3
 
H]thymidine-labeled virus
was bound to cells at 4
 
8
 
C for 2 h. The cells were washed to remove un-
bound virus, and then shifted to normal medium at 37
 
8
 
C and 5% CO
 
2
 
 for
various lengths of time. The cells were transferred back to ice, washed,
and stored at 4
 
8
 
C until the last time point. All the following treatments
were performed at 4
 
8
 
C. The cells were washed with cold, protein-free PBS
and incubated with 1 ml per well proteinase K (2 mg/ml in PBS; Boeh-
ringer Mannheim GmbH, Mannheim, Germany). After 1 h, 1 ml of PBS
containing 1.25 mM PMSF and 3% (wt/vol) BSA was added to stop fur-
ther proteolysis. The cells were collected, the wells were rinsed with wash
buffer (PBS containing 0.2% BSA), and the cells along with the wash
buffer were spun at 1,500 rpm for 10 min. The pellet was resuspended and
pelleted again; scintillation liquid was added to the resuspended pellet (0.5
ml) and counted in a liquid scintillation counter. The amount of internal-
ized virus was expressed as cell-associated [
 
3
 
H]thymidine counts (mean
value from triplicates). Control cells, which were not warmed up after vi-
rus binding, showed that the proteinase K treatment removed 90–95% of
cell-bound virus.
 
Light Microscopy
 
Vero cells grown on coverslips for 1–2 d to 
 
z
 
70% confluency were in-
fected with HSV-1 at an MOI of 50 PFU per cell in the presence of cyclo-
heximide. In one protocol, cells were fixed with 3% (wt/vol) paraformal-
dehyde for 20 min followed by quenching remaining fixative using 50 mM
NH
 
4
 
Cl for 10 min and permeabilization with 0.1% TX-100 for 4 min.
Here, all incubations were carried out in PBS, pH 7.4, at room tempera-
ture. In an alternative protocol, the cells were preextracted with 0.5% TX-
100 for 10 s at 37
 
8
 
C in an MT stabilizing buffer (80 mM Pipes, 2 mM
MgSO
 
4
 
, pH 6.8, 10 
 
m
 
M taxol), and then fixed in 100% methanol at 
 
2
 
20
 
8
 
C
for 4 min. Before immunolabeling at room temperature, the cells from
both protocols were washed again in PBS, transferred to 10% normal goat
serum for 30 min, and then labeled with the primary antibody in 10% goat
serum for 20 min. The coverslips were rinsed three times for 5 min and in-
cubated with fluorescently labeled secondary antibodies in 10% goat se-
rum for 20 min. For double-labeling experiments, the two primary and the
two secondary antibodies were applied simultaneously. After extensive
washing and one short wash in water, the coverslips were mounted in
Mowiol containing 2.5% (wt/vol) 1,4-diazabicyclo-[2.2.2]octane on glass
slides and examined with an Axiophot fluorescence microscope (Carl
Zeiss, Inc., Thornwood, NY) or a confocal fluorescence microscope (Bio
Rad Laboratories, Hercules, CA). Image processing was performed using
Adobe Photoshop (Adobe Systems, Inc., Mountain View, CA).
 
Assay for Viral Protein Synthesis
 
Confluent Vero cells grown in 6-cm tissue-culture dishes were infected
with HSV-1 at an MOI of 0.5 PFU per cell for 30 min at 37
 
8
 
C and 5% CO
 
2
 
in MEM containing 0.2% (wt/vol) BSA, and then incubated further in
normal growth medium. At various time points, they were transferred to
4
 
8
 
C, washed three times with ice cold PBS, scraped, pelleted, and resus-
pended in 0.3 ml per dish lysis buffer (MNT with 0.5% TX-100, 2 mM
DTT, 2 mM EDTA, and 10 
 
m
 
g/ml each of chymostatin, leupeptin, anti-
pain, and pepstatin). The nuclei were removed by centrifugation at 5,000
rpm for 5 min. A 50-
 
m
 
l aliquot of the resulting supernatant was used for
protein assays (bicinchoninic assay; Pierce Chemical Co., Rockford, IL),
and 0.2 ml were solubilized in 5 
 
3
 
 Laemmli sample buffer. Equal amounts
of protein were loaded onto a 7.5% SDS polyacrylamide gel for electro-
phoresis, and the separated proteins were blotted onto nitrocellulose
membranes using a semidry blotter. After blocking in 5% lowfat milk in
PBS with 0.1% Tween-20, the membranes were incubated with either
anti–NC-1 and calnexin or anti–ICP4 and calnexin, followed by HRP-con-
jugated anti–rabbit or anti–mouse secondary antibody (Pierce Chemical
Co.). The secondary antibodies were visualized by enhanced chemilumi-
nescence detection (Amersham Corp. or Pierce Chemical Co.) and Kodak
film (Eastman Kodak Co., Rochester, NY). The bands were quantified by
densitometry using a Visage 200 digital gel scanner (Bioimage, Ann Ar-
bor, MI). The amount of viral protein (ICP4 or VP5) was normalized for
the amount of cellular protein (calnexin).
 
Results
 
Early Events during HSV-1 Entry
 
Due to the large size of HSV-1 virions and capsids, early
virus cell interactions can be readily visualized by EM
(Campadelli-Fiume et al., 1988; Fuller et al., 1989; Lycke
et al., 1988). We followed the incoming capsids at different
stages of entry in Vero cells (Fig. 1). The extracellular, sur-
face-bound virus particles had the familiar features of a
herpes virus: a membrane envelope with spikes, a capsid
with an electron-dense DNA core, and a tegument layer
between the capsid and the envelope (Fig. 1, 
 
a
 
 and 
 
b
 
). Im-
ages of fusion between the viral envelope and the plasma
membrane were readily obtained (Fig. 1, 
 
c
 
 and 
 
d
 
). After
fusion, the capsids appeared to separate from the bulk of
the tegument since an electron-dense mass remained asso-
ciated with the cytoplasmic surface of the plasma mem-
brane (Fig. 1, 
 
e
 
 and 
 
f
 
, 
 
arrowheads
 
; see also Campadelli-
Fiume et al., 1988; Fuller et al., 1989).
After 1 h, the first capsids had reached the nucleus and
attached themselves to the nuclear pore complexes (Fig. 1,
 
g
 
 and 
 
h
 
; see also Batterson et al., 1983; Lyke et al., 1988).
They seemed to bind to cytsosolic fibers emerging from
the pores (see 
 
arrowheads
 
 in Fig. 1 
 
h
 
). Since most of the
capsids on the nuclear envelope lacked the electron-dense
central mass, DNA release had apparently occurred. At
later time points, some empty capsids were also seen free
in the cytosol without connection to the nucleus. Occa-
sionally, 1 h postinfection and later, intact and partially de-
graded virions were also seen in endosomes and lyso-
somes, indicating that a fraction of the inoculum was taken
up by endocytosis.
The rate and efficiency of cell surface binding and sub-
sequent internalization was assayed quantitatively using
[
 
3
 
H]thymidine-labeled HSV-1. To monitor binding, cells 
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were incubated with labeled virus at an MOI of 10, 50, or
100 at 4
 
8
 
C, and the cell-associated radioactivity was mea-
sured at different times. As previously reported, a continu-
ous increase in virus binding was observed up to 4 h with
no signs of saturation (Fig. 2 
 
a
 
; McClain and Fuller, 1994;
Shieh et al., 1992). At 2 h—the adsorption period used in
all subsequent experiments—
 
z
 
40% of the added virus
was bound.
To follow internalization biochemically, a protease pro-
tection assay was used (Helenius et al., 1980). After a 2-h
binding period in the cold, the cells were warmed up to
37
 
8
 
C for different periods of time to initiate penetration.
Thereafter, they were chilled to 4
 
8
 
C and treated with pro-
teinase K to detach remaining cell surface viruses. The frac-
tion of virus protected from the protease increased rapidly
after warming (Fig. 2 
 
b
 
) with a half-time of internalization
of 8 min. The overall protease resistance reached a level of
70% within 30 min. The efficiency and rate of internaliza-
tion was identical over a multiplicity range from 3 
 
3
 
 10
 
2
 
4
 
–10
MOI. Treatment of the cells with nocodazole, a drug that
depolymerizes MT (Fig. 2 
 
b
 
, 
 
ND
 
), or with cytochalasin D,
which depolymerizes actin filaments (not shown), had no
effect, either on the efficiency of binding and internaliza-
tion or on the kinetics of internalization. Consistent with
previous reports using acid inactivation and plaque assays
to assess virus internalization (Huang and Wagner, 1964),
these results showed that HSV-1 penetration occurs rap-
idly and efficiently.
 
Transport of Capsids from the Plasma Membrane
to the Nucleus
 
Indirect immunofluorescence microscopy was next used to
analyze the transport of individual capsids from the cell
periphery to the nucleus. The antibodies used were either
against VP-5 (anti–NC-1) or VP19c (anti–NC-2), the two
major capsid proteins, or against purified whole capsids
(anti-HC and anti-LC). All the antibodies gave similar re-
sults and had in common that they stained capsids that
were in the cytosol (Fig. 3, 
 
1 h
 
) but not capsids present in
surface-bound intact viruses (Fig. 3, 
 
0 h
 
). Presumably, this
useful selectivity was caused by antigen accessibility; the
relevant capsid epitopes in the intact virus particles were
probably obscured by envelope and/or tegument compo-
nents. In contrast, anti-capsid antibodies labeled viral
capsids on thawed cryosections (Sodeik, B., M.W. Eber-
sold, and A. Helenius, unpublished observations).
The capsids in the cytoplasm appeared as small, in-
tensely labeled spots (Fig. 3, 
 
arrows
 
, 
 
1 h
 
). Using immuno-
electron microscopy on thawed ultrathin cryosections, we
confirmed that these spots represented single capsids (not
shown). All the structures labeled in the cytosol or at the
Figure 1. Entry and uncoating of HSV-1. Ultrathin Epon sections of Vero cells infected with HSV-1 at an MOI of 500 in the presence of
cycloheximide (CH). After 2 h of virus binding at 48C, the cells were either fixed immediately (a and b), or warmed up for 30 (c–f) or 60
min (g and h). (a and b) Binding. The main morphological features of the intact virus bound to the plasma membrane (PM) are the viral
envelope (b, arrowhead) with the viral spikes (a, arrowhead), the viral capsid (arrow), and the electron-dense viral DNA genome within
the capsid. (c and d) Fusion. Upon warming up, the viral envelope fuses with the plasma membrane, and the capsid (arrow) and the teg-
ument proteins are released into the cytosol. (e and f) Release of the capsid. Preparations, which display a prominent contrast of the teg-
ument, show that the tegument (arrowheads) stays behind at the PM. (g and h) Binding to the nuclear pore. At later time points, the
capsids (arrows) have arrived at the nuclear envelope (NE), where they are exclusively located in close apposition to the nuclear pore
complexes. Occasionally, fibers emanating from the pores (arrowheads) are visible, to which the capsids seem to bind. Almost all of the
capsids at the nuclear pores appear empty and have lost the electron-dense DNA core. Bar, 100 nm.Sodeik et al. Microtubule-mediated Transport of Viral Capsids 1011
nuclear membrane by antibodies directed against the cap-
sid or against VP5 represented single viral capsids (not
shown). The number of fluorescently labeled spots in-
creased continuously during the first hour of warming. In
addition, their distribution within the cell changed with in-
creasing time: from the cell periphery toward the nucleus
where they accumulated at the nuclear rim (Fig. 3, 2 h).
After 4 h, virtually all the spots were localized at the nu-
clear membrane (Fig. 3, 4 h) where several hundred
capsids could be seen. Thus, incoming cytosolic capsids
were transported efficiently from the periphery to the host
nucleus.
Capsids Bind to Microtubules
Double immunofluorescence microscopy using anti-capsid
and anti-tubulin antibodies showed that most of the
capsids that were not bound to the nucleus were associ-
ated with MT (Fig. 4, a and b). Moreover, in many cells,
capsids were seen to concentrate around the MT organiz-
ing center (MTOC) (Fig. 4 b). The close association of
capsids with MT was confirmed by EM (Fig. 4, c–e). Nu-
merous cytoplasmic capsids were seen in close proximity
to cytoplasmic filaments with the expected 24-nm width
and MT-like morphology. Typically, the distance between
the capsid surface and the tubules was z50 nm, suggesting
the presence of additional tethering components. The viral
DNA inside the MT-associated capsids could be seen as a
darkly stained material.
The tubules were unambiguously identified as MT by
antitubulin labeling of specimen that had been preex-
tracted with TX-100 before fixation. After such extraction,
thicker sections could be viewed, allowing the analysis of
MT over longer distances. The MT-associated capsids gen-
erally contained the viral DNA (Fig. 4 f, arrows). At later
time points, most of the capsids were empty and typically
located at the nuclear pores and not at the nuclear enve-
lope membrane (Fig. 4 g). Most of these capsids did not
contain DNA (Fig. 4, g and h). At 4 h postinfection, there
were occasionally empty capsids localized on MT in close
proximity to the nucleus (not shown). Whenever extracel-
lular viruses were observed in these TX-100 extracted
samples, they were surrounded by very-electron dense ma-
terial, which probably represented the viral glycoproteins
and tegument proteins that were apparently not removed
during extraction (Fig. 4 h, curved arrow).
Quantitation of HSV-1 Entry and Capsid Transport
To quantify the kinetics of the cytosolic capsid transport,
we determined the subcellular localization of the incoming
virus by EM at various time points postinfection at an
MOI of 500 (Fig. 5). To compare this experiment with the
immunofluorescence microscopy, ultrathin sections were
cut parallel to the substrate through the basal region of the
cells (see Fig. 5 a). For each time point, 25 electron micro-
graphs were taken in a systematic random fashion, and the
number and localization of cytosolic capsids was deter-
mined. Cytosolic capsids (Fig. 5 b) were localized at the
plasma membrane (Fig. 5 c), in the cytosol without obvi-
ous connection to any organelle (Fig. 5 d), at MT (Fig. 5 e),
or at the nucleus (Fig. 5 f).
After warming, the total number of cytosolic capsids in-
creased rapidly, reaching a peak after 60 min (Fig. 5 b). At
later times the number of cytosolic capsids declined, sug-
gesting that the capsids were ultimately disassembled. We
also scored whether the cytosolic capsids contained the
electron-dense viral DNA core or whether they appeared
empty (see Fig. 1). Up to 60 min after internalization, no
empty capsids were detected, whereas after 2 h 20% and
after 4 h 64% had lost their electron-dense DNA core
(Fig. 5 b). Virions in endosomes peaked at 1 h and sharply
declined thereafter. They may have been degraded or re-
Figure 2. Efficiency and kinetics of HSV-1 binding and internal-
ization. (a) Using [3H]thymidine-labeled virus at different multi-
plicities of infection (MOI), the amount of virus bound to cells at
48C was quantified after various time points. There is no apparent
saturation of virus binding to Vero cells. After 2 h, z40% of the
virus added bound. (b) Using [3H]thymidine-labeled virus at dif-
ferent MOIs, the amount of virus internalized into cells was quan-
tified after various time points. At time 0 min (equals 2 h of virus
binding at 48C), proteinase K treatment removes .95% of the vi-
rus bound to the plasma membrane. Upon warming up to 378C
and viral fusion, the virus is protected within the cells from the
protease treatment. After 30 min, the maximal amount of virus,
z70% of the bound virus, is internalized. The half-time (t1/2) of
internalization is 8 min. Depolymerization of microtubules by no-
codazole (ND) has no effect on the kinetics and the amount of in-
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cycled back to the cell surface, or capsids could have been
released by fusion into the cytosol.
At 15 min postinfection, almost 70% of all cytosolic
capsids were localized within 100 nm of the plasma mem-
brane (see Figs. 1, c–f, and 5 c). All of the capsids close to
the plasma membrane contained the viral DNA core. At 1 h
postinfection, most of the cytosolic capsids (almost 80%)
had an intermediate location; they were neither close to
the plasma membrane or to the nucleus (Fig. 5, d and e). A
significant fraction (10% of all cytosolic capsids) colocal-
ized with MT (see Figs. 4, c–e, and 5 e). Since the capsids
(125 nm) are considerably larger than the section thick-
ness (60–70 nm), the figure for colocalization with the MT
was most likely an underestimation. Of the cytosolic cap-
Figure 3. Subcellular distribution of incoming HSV-1 capsids. Conventional immunofluorescence microscopy of Vero cells infected
with HSV-1 at an MOI of 50 in the presence of CH. The cells were fixed in 3% PFA, permeabilized with 0.1% TX-100, and labeled with
anti-HC, an antibody generated against purified capsids. After 2 h of virus binding at 48C (0 h), there is no signal. At 1 h PI, numerous
cytoplasmic capsids (arrows) distributed within the entire cytoplasm are detectable. At 2 h PI, the capsids begin to accumulate at the nu-
cleus. At 4 h PI, most of the capsids decorate the nuclei. Note that at 1 h, the focus was close to the coverslip, whereas at 2 and 4 h, it was
at the nuclear membrane.
Figure 4. Incoming HSV-1 capsids colocalize with MTs. (a) Conventional immunofluorescence microscopy. Vero cells infected at an
MOI of 50 in the presence of CH were fixed in methanol at 2 h PI, and double labeled with anti-VP5 (NC-1; FITC anti–rabbit) and anti-
tubulin antibodies (IA2; rhodamine anti–mouse). The FITC and the rhodamine signals were documented simultaneously using the
FITC filter set. Almost all capsids (arrows) not localized to the nucleus (N) colocalize with microtubules. (b) Confocal immunofluores-
cence microscopy. Vero cells infected at an MOI of 50 in the presence of CH were fixed in methanol 2 h PI, and double labeled with
anti-capsid (HC, white) and anti-tubulin antibodies (IA2, gray). Almost all capsids not localized to the nucleus (N) colocalize with mi-
crotubules. Note that in some cells, the viral capsids accumulate at the microtubule-organizing center (MTOC). (c–e) Conventional EM. At
1 h postinfection, Vero cells infected at an MOI of 500 in the presence of CH were fixed with 2% glutaraldehyde in PBS. Epon sections
were cut parallel to the substrate. Numerous incoming viral capsids are localized to microtubules (MT) as identified by their typical mor-
phology, localization, and their 24-nm diameter. (f–h) Immunoelectron microscopy. Vero cells infected at an MOI of 500 in the presence
of CH were extracted at 1 h (f) or 4 h PI (g and h) with 0.5% TX-100 in MT buffer before fixation. They were labeled with rabbit anti–
tubulin followed by protein A–9 nm gold, and Epon sections were cut parallel to the substrate. The cytoskeleton, nucleus, and nuclear
pore complexes (NPC), as well as cytoplasmic capsids, were preserved excellently, whereas all membranous organelles were extracted.
The microtubules (MT) are easily identified, since they are heavily decorated with antibody and protein A–gold. In rather thick sections
(f), the microtubules can be traced over long distances, and many capsids (filled arrows) are localized on them. These capsids still con-Sodeik et al. Microtubule-mediated Transport of Viral Capsids 1013
tain their electron-dense DNA core. At later time points (g and h), most of the capsids have lost their electron-dense core (h, open ar-
row) and are mostly located in close proximity to the nucleus. Very often the capsids are bound directly to the outer ring of the nuclear
pore complex (g, NPC). Virions bound to the plasma membrane (h, curved arrowhead) have lost the trilaminar appearance of their
membrane, but apparently a lot of glycoprotein and tegument remains attached to them, causing a distinct morphology easily distin-
guished from cytoplasmic capsids (g). Bar, 100 nm.The Journal of Cell Biology, Volume 136, 1997 1014
sids, only one capsid (0.9% of all capsids at 4 h postinfec-
tion) was seen to colocalize with intermediate filaments
(not shown).
Cytosolic capsids arrived at the nucleus at 2 h postinfec-
tion, and at 4 h, the majority of cytosolic capsids (.60%)
was localized to the nucleus (Fig. 5 f). At the ealier time
points (up to 1 h), ,4% of the cytosolic capsids were lo-
cated at the nucleus. Of the nuclear capsids, 68% at 2 h
and 87% at 4 h were empty, suggesting that DNA release
occurred after arrival at the nucleus. The vast majority of
empty capsids were localized to the nucleus (Fig. 5 g). All
capsids at the nucleus were localized to the nuclear pore
complexes (see Fig. 1, g and h).
In summary, the electron microscopic experiment con-
firmed the immunofluorescence microscopy data. Cyto-
solic capsids were efficiently transported from the plasma
membrane via the cytosol to the nuclear pore complexes.
During transit, a significant fraction attached to MT. Empty
capsids appeared soon after their arrival at the nucleus,
and some of these were released into the cytosol. Ulti-
mately, the capsids seemed to disassemble and disappear
because the overall number of cytosolic capsids decreased
late in infection. Interestingly, the appearance of cytosolic
capsids under the plasma membrane peaked before the
transport of virions into endosomes, strongly suggesting
that the early cytosolic capsids were indeed derived from
fusion of the virus at the plasma membrane rather than by
fusion from endosomes.
Reduced Capsid Transport to the Nucleus
without Microtubules
To determine whether efficient capsid transport via the cy-
tosol depended on an intact cytoskeleton, cells were in-
fected at an MOI of 50 for 2 h in the presence of drugs that
affect MT or actin filaments. Immunofluorescence micros-
copy showed that neither taxol, a drug that prevents the
disassembly of MT (Wilson and Jordan, 1994), nor cyto-
chalasin D, a drug that causes depolymerization of actin
filaments (Cooper, 1987), affected capsid transport to
the nucleus (Fig. 6 a, upper panels). In contrast, capsid ac-
cumulation at the nuclear membrane was significantly re-
duced by colchicine, vinblastine, and nocodazole (Fig. 6 a,
lower panels). These drugs interact with tubulin by differ-
ent molecular mechanisms (Wilson and Jordan, 1994). La-
beling with anti-tubulin confirmed that colchicine and no-
codazole depolymerized MT, whereas vinblastine caused
tubulin paracrystal formation (not shown). In the presence
of these drugs, the majority of capsids remained scattered
throughout the cytosol. To test whether the effect of no-
Figure 5. Time course of HSV-1 entry. Vero cells infected at an
MOI of 500 in the presence of CH were fixed at various times
postinfection with 2% glutaraldehyde in PBS and embedded in
Epon for EM analysis. (a) Schematic cross-section perpendicular
to the substrate through an adherent Vero cell. For quantitation,
25 random electron micrographs obtained from sections cut par-
allel to the substrate through the basal part of the cells were
taken in a systematic fashion for each time point. “Basal” is de-
fined as being within 2 mm distance from the substrate (30 sec-
tions of z50–70 nm). (b) The total numbers of cytosolic capsids
(full and empty), cytosolic empty capsids, and virions in endo-
somes were determined for each time point. The number of cyto-
solic capsids increased rapidly until 1 h postinfection. At later
time points, less cytosolic capsids were detected, suggesting that
they were ultimately disassembled. In addition, the subcellular lo-
calization of each capsid was determined and the numbers were
expressed as a percentage of the total (c–g). (c) At the earliest
time point of 15 min, the majority of cytosolic capsids was local-
ized close to the plasma membrane, from where they disappeared
rapidly later. (d) Several capsids could not be localized to a par-
ticular organelle. At 1 h postinfection, there was the highest
amount of those capsids, which were apparently free in the cyto-
sol. (e) A significant portion of all cytosolic capsids, namely 10%
at 1 h postinfection, colocalized transiently with microtubules. (f)
Capsids began to appear at the nuclear pores at 2 h postinfection,
and at 4 h, 60% of all cytosolic capsid had reached the nucleus.
(g) The appearance of empty cytosolic capsids coincided with the
arrival at the nucleus. Only at 4 h postinfection, there was a very
small portion of empty, cytosolic capsids. N, nucleus; PM, plasma
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codazole was reversible, the cells were analyzed 2 h after
drug removal. At this time, the MT had repolymerized,
and the previously dispersed capsids were concentrated on
the nuclear rim (Fig. 6 b).
Since we were unable to quantify the localization of the
fluorescent spots representing cytosolic capsids reliably,
we infected Vero cells at an MOI of 150 in the presence or
absence of nocodazole and analyzed the embedded cell
pellets by quantitative EM. For each experimental condi-
tion, 50 electron negatives were taken in a systematic, ran-
dom fashion and the localization of cytosolic capsids was
determined (Fig. 7, a and b). After 2 h of infection, 31% of
the cytosolic capsids had reached the nucleus, and only
25% were still in close proximity to the plasma membrane.
In contrast in the absence of MT, none had reached the
nucleus, and 58% were still in the region close to the
plasma membrane. After 4 h postinfection, 75% of all cy-
tosolic capsids had reached the nucleus, 14% were at the
plasma membrane, and the remaining 11% were present
in the cytosol. In the presence of nocodazole, only 47% of
the cytosolic capsids had reached the nucleus, 18% were
still at the plasma membrane, and 36% were in the cytosol
distant from both the plasma membrane and the nucleus.
As nocodazole, vinblastine, and colchicine all affect the
network of MT (Wilson and Jordan, 1994), we concluded
that MT are directly or indirectly involved in the rapid
transport of capsids from the cell periphery to the nucleus
in Vero cells. In cells devoid of functional MT, the arrival
of capsids at the nucleus was significantly delayed.
Viral Infection in the Absence of Microtubules
Whether nocodazole would have an effect on productive
infection was determined by monitoring the onset of viral
protein synthesis in the presence or absence of the drug.
Cell extracts prepared after different periods of infection
were subjected to immunoblotting using antibodies against
an early HSV-1 protein, ICP4, and a late structural pro-
tein, VP5. The results in Fig. 7 c show that the synthesis of
both viral proteins was delayed and reduced in the ab-
sence of MT. Calnexin, an integral membrane protein of
the ER (Hammond and Helenius, 1994), was used as a
control and remained constant. Labeling with [35S]me-
thionine demonstrated that nocodazole had no overall ef-
fect on protein synthesis in uninfected or HSV-1–infected
Vero cells (not shown).
When immunofluorescence microscopy using ICP4 was
performed, we found that, under control conditions, viral
protein synthesis commenced in many cells already at 2 h
postinfection. In contrast, in the presence of nocodazole,
only very few cells showed ICP4 labeling. At 4 h postin-
fection, all control cells were strongly labeled for ICP4,
whereas in the absence of MT, significantly less cells show
strong labeling for ICP4 (data not shown). However, at
later time points, all cells synthezised ICP4, in the pres-
ence and absence of MT.
Thus, depolymerization of MT delayed the onset of viral
protein synthesis in cultured fibroblasts, but did not pre-
vent viral infection per se.
Dynein Colocalizes with Incoming Capsids
Our results strongly suggested that incoming herpes
capsids move along MT toward the nucleus. Therefore, we
ask whether they would use host MT-dependent motors
for their transport. Since the antibody against tubulin of-
ten obscured the morphology of putative tethering factors
located between the viral capsids and the MT (see Fig. 4),
we repeated these experiments without immunolabeling.
Electron-dense material was usually attached to the verti-
ces of the capsids that were associated with MT (Fig. 8).
The morphology of the appendages was variable, but, in
some cases (Fig. 8 d, arrow), they had the dimensions and
the shape of cytoplasmic dynein, a minus end–directed
MT-dependent motor. Dynein is a Y-shaped protein com-
plex with a length of z50 nm. It is connected to its cargo
via the stalk and to MT through two 14-nm globular do-
mains (Gilbert and Sloboda, 1989; Vale, 1990; Vallee et al.,
1988).
To test whether cytoplasmic dynein was, indeed, associ-
ated with the capsids, we used an affinity-purified anti-
body directed against the heavy chain of cytoplasmic dy-
nein (Vaisberg et al., 1993). Immunoelectron microscopy
with the anti-dynein antibody was performed on ultrathin
cryosections of in situ fixed cells 1 or 2 h after initiation of
virus entry. In addition to a low level of labeling of the cy-
toplasm, dynein was found to be localized on the surface
of endosomes (Fig. 9 h), mitochondria (Fig. 9 a), and the
Golgi apparatus (Fig. 9 a). Very few gold particles were
seen over the nucleus and the mitochondrial matrix (Fig.
9, a, c, and d). The mitochondria, which do not contain dy-
nein, served as a background control. Compared with the
mitochondrial matrix, there was a slightly higher labeling
in the nuclei, and the cytoplasm was labeled 2.3-fold
higher than background (Table I).
In cells containing incoming HSV-1 capsids, dynein
was, in addition, found associated with many of the capsids
(Fig. 9, a–f). Capsids directly underneath the plasma mem-
brane (Fig. 9 g) and within the cytoplasm (Fig. 9 b), as
well as capsids in close proximity to the nucleus (Fig. 9, a,
c, and d), were labeled with anti-dynein. On average, 13%
of the cytoplasmic capsids were labeled (Table I). Capsids
of intact virions, either extracellular (Fig. 9 f) or within en-
dosomes (Fig. 9, g and h), were not labeled. Only 1.5% of
all capsids present in virions had colloidal gold particles in
close proximity (Table I). Thus, the labeling density was
eightfold higher on cytosolic capsids compared with cap-
sids within virions, ruling out the possibility that the anti-
dynein antibody showed cross-reactivity to capsid proteins.
Given that the labeling efficiency using this technique does
not exceed 10%, e.g., only 10% of the primary antibody
present on the sections is detected by protein A–gold
(Griffiths, 1993a), these results showed that incoming cy-
tosolic viral capsids associated with cytoplasmic dynein.
Discussion
HSV-1 causes a range of diseases from benign common cold
sores to life-threatening encephalitis. It infects epithelial
cells of mucocutaneous membranes, and, as other a her-
pesviridae, it establishes latent infections in sensory gan-
glia (Whitley and Gnann, 1993). It is thought to enter neurons
by fusion at the presynaptic membrane, after which the
capsid is transported along the axon to the nucleus (Hill
et al., 1972; Lycke et al., 1988; Roizman and Sears, 1989;The Journal of Cell Biology, Volume 136, 1997 1016
Topp et al., 1994). The efficient infection of neurons and
other terminally differentiated cells has made HSV-1 a
useful vehicle for gene delivery with potential for gene
therapy in the human brain (Glorioso et al., 1995; Karpati
et al., 1996).
The biochemical and morphological assays used in our
study showed that HSV-1 entry into Vero cells is both
rapid and efficient. Over a broad range of multiplicities,
we found that z70% of bound virus penetrated with a
half-time of z8 min. More than 60% of the capsids deliv-
ered to the cytosol were transported to the nucleus within
4 h of uptake, and binding to fibers extending from the
nuclear pore complexes seemed to occur. The ratio of par-
ticles to plaque-forming units for HSV-1 is between 10 and
50 (Frenkel et al., 1975; McLauchlan et al., 1992; Smith,
1964; Watson et al., 1963). Thus, if cells were infected at an
MOI of 50, and 40% of these bound, the number of parti-
cles entering the cells was 140–700 according to the pro-
teinase K assay. We determined that 60% of the internal-
ized virus, namely 80–420 particles, uncoat their viral
genome within 4 h postinfection as measured by a DNase
protection assay (Ojala, P., B. Sodeik, M.W. Ebersold, and
A. Helenius, manuscript in preparation).
A majority of the capsids remained associated with nu-
clear pores after releasing their DNA (see also Batterson
et al., 1983; Lycke et al., 1988). The apparent transient sta-
bility of the empty capsids contrasts with adenovirus, an-
other virus that delivers its DNA to the nucleus through
the nuclear pore complexes, for which no empty capsids
could be detected at the nuclear pore complexes (Greber
et al., 1993). We cannot formally rule out that, even though
the herpes capsids appeared empty at the nuclear mem-
brane, viral DNA release had not been completed yet.
Our results demonstrate that MT are involved in capsid
transport from the cell surface to the nucleus. Since the
distance from the plasma membrane to the nucleus in
Vero cells is not as large as in neurons, MT-assisted trans-
port was not essential for infection, but it accelerated both
the transfer of the capsids to the nucleus and the onset of
viral protein synthesis. Having first detached from most of
the tegument proteins at the plasma membrane, the cap-
sids moved in minus end direction along MT to the MTOC.
From there, they were transferred to the nuclear pores by
unknown mechanisms. At early times (1–2 h PI), the ma-
jority of the capsids associated with the nuclear membrane
proximal to the MTOC, but later the distribution became
more homogenous around the nucleus.
Nocodazole and colchicine, which both depolymerize
MT, and vinblastine, which causes MT paracrystal forma-
tion, reduced capsid accumulation at the nuclear envelope.
These drugs were also reported to reduce the amount of
infectious HSV-1 recovered from rat dorsal root ganglia
infected in vitro (Kristensson et al., 1986) and from the
trigeminal ganglia after inoculation of the murine cornea
(Topp et al., 1994). We think that it is very likely that
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membrane in our system (see Fig. 5 a) reached the nucleus
independent of MT, since the distance between the api-
cal plasma membrane and the nuclear membrane is only
z200–300 nm. Thus, the larger the distance between the
plasma membrane where the virion had bound and the nu-
cleus, the more the transport to the nucleus depended on
MT. In contrast with the results obtained in neurons (Kris-
tensson et al., 1986), taxol, which stabilizes MT, did not re-
duce the efficiency of capsid transport, suggesting that the
dynamic turnover or “treadmilling” of MT was not re-
quired for capsid transport in Vero cells. Depolymeriza-
tion of actin filaments by cytochalasin D had no effect ei-
ther on HSV-1 internalization or transport to the nucleus.
The presence of dynein heavy chains in the material at-
tached to the cytosolic capsids indicated that the MT-medi-
ated transport was powered by cytoplasmic dynein. Cyto-
plasmic dynein is a multisubunit protein complex of 1,270
kD consisting of two heavy chains, two to three intermediate
chains, and a variable number of small subunits (Holzbaur
and Vallee, 1994; Schroer, 1994). It has a length of z40–50
nm and a shape reminiscent of the letter Y. The two head
domains contain the MT binding and ATPase sites, while
the base interacts with the cargo (Gilbert and Sloboda,
1989; Vale, 1990; Vallee et al., 1988). Dynein is responsible
for minus end–directed movement of chromosomes and
membrane organelles along MT (Cole and Lippincott-
Schwartz, 1995; Mitchison, 1988). Since the plus ends of
MT are localized in the periphery of Vero cells close to the
plasma membrane and the minus ends are anchored at the
perinuclear MTOC, dynein seems a logical choice as a mo-
Figure 6. Reduced transport of capsids to the nucleus in the absence of MTs. Immunofluorescence microscopy of Vero cells infected
with HSV-1 for 2 h at an MOI of 50 in the presence of CH and drugs affecting the cytoskeleton. (a) Cytoskeletal drugs. Under control
conditions, almost all capsids accumulate around the nucleus. If the cells were infected in the presence of nocodazole, colchicine, or vin-
blastine, respectively (lower panel), there is no accumulation of viral capsids at the nucleus; instead, the capsids are scattered throughout
the entire cytoplasm. In cells infected in the presence of taxol or cytochalasin D, the capsids accumulate at the nucleus (upper panel).
The cells were fixed in 3% PFA, permeabilized with 0.1% TX-100, and labeled with an antibody directed against purified capsids (HC).
(b) Reversibility. In the presence of nocodazole, the amount of viral capsids localized to the nucleus is drastically reduced, whereas, af-
ter a 2-h chase in nocodazole-free medium, the capsids accumulate around the cell nuclei. Cells were infected in the presence of nocoda-
zole for 2 h, fixed immediately (left panels), or washed and further incubated in normal medium for an additional 2 h before fixation
(right panels). After extraction with 0.5% TX-100 in MT buffer and fixation in methanol, the cells were double labeled with anti-tubulin
(left panels) and anti-capsid (HC, right panels).The Journal of Cell Biology, Volume 136, 1997 1018
Figure 7. Quantitation of capsid transport and viral protein syn-
thesis in the absence of MTs. Vero cells were infected at an MOI
of 170 in the presence of CH and in the absence or presence of
nocodazole to depolymerize microtubules. They were fixed at 2
(a) or 4 (b) h postinfection with 1% GA and collected by scraping
and pelleting, and Epon sections were prepared. For quantita-
tion, 50 random electron micrographs were obtained in a system-
atic fashion for each time point and both treatments. The subcel-
lular localization of each cytosolic capsid was determined. (a) At
2 h postinfection in the presence of microtubules, the majority of
cytosolic capsids was localized in the cytosol, and a significant
fraction had reached the nucleus. In the absence of microtubules,
the majority of capsids remained at the plasma membrane (PM),
some were in the cytosol, and none had reached the nucleus. (b)
At 4 h, .70% of the capsids had reached the nucleus. In the pres-
ence of nocodazole, a much smaller fraction was transported to
the nucleus, and more capsids remained at the plasma membrane
and in the cytosol. (c) Immunoblot. Vero cells were infected at an
MOI of 0.5 (without CH!) in the absence or presence of 5 mM no-
codazole for various times. The cells were harvested and lysed in
0.5% TX-100 in buffer, the nuclei were pelleted, and the superna-
tants were analyzed by immunoblotting. To monitor viral protein
synthesis, antibodies to ICP4, an early viral protein, and to VP5, a
late viral protein, were used. Calnexin, a membrane-bound ER
protein, was used as a cellular marker protein. Equal amounts of
protein were loaded per lane, and the amount of ICP4 or VP5
was normalized with the amount of calnexin. ICP4 synthesis com-
mences at 2 h PI, whereas VP5 is first detectable at 5 h PI. The
amount of ICP4 is maximal after 6 h PI. In contrast, VP5 synthe-
sis increases during the whole time course of the experiment. At
all time points, lower amounts of both, ICP4 and VP5, are synthe-
sized in the absence of microtubules.
Figure 8. Incoming HSV-1 capsids display appendices at their
vertices. At 1 h PI, Vero cells infected at an MOI of 500 in the
presence of CH were extracted with 0.5% TX-100 in MT buffer
for 2 min at 378C and fixed in 1% GA in MT buffer. They were
labeled with anti-tubulin followed by protein A–9 nm gold (a) or
embedded directly (b–d), and Epon sections were cut parallel to
the substrate. All viral capsids display some appendages on their
outside (arrowheads). The appendages are visible at three, four,
five, or all six corners visible in a section, which represent the
pentons of a viral capsid. Some of the appendices have a mor-
phology very similar to purified cytoplasmic dynein (large arrow
in d): a large globular stalk with two smaller globular head do-
mains. The capsid size is z100–110 nm; the dynein-like appendi-
ces are z50 nm. In thick sections of golden color, the appendices
are often buried in cytoskeletal material (b and d), whereas in
very thin sections of grey color (a and c), they are very promi-
nent. The appendices have all kinds of different morphology with
varying sizes and electron density, but they are always located at
the pentons.Sodeik et al. Microtubule-mediated Transport of Viral Capsids 1019
Figure 9. Anti-dynein antibodies label incoming viral HSV-1 capsids. Thawed cryosections of Vero cells infected for 1 (c) or 2 h (a, b, and
d–h) in the presence of CH at an MOI of 500 were labeled with rabbit antibodies followed by protein A–5 nm (a–d, and g) or 10 nm gold
(e, g, and h). About 5% of the incoming viral capsids (a–f, and h) are labeled by anti-dynein (arrows), an affinity-purified antibody made
against a recombinant fragment of dynein heavy. Labeled capsids are localized close to the plasma membrane (g, PM), at the nuclear
envelope (c and d), or within the cytoplasm without obvious connection to either one (b). Note that the capsids within the extracellular
virions (f) or within the endosomes (g and h, E) are not labeled. Anti-dynein also labels the membranes of mitochondria (a, M), endo-
somes (h, E), and the Golgi complex (a, G) and diffusely the entire cytoplasm, whereas the mitochondrial matrix (a, b, and d) or the nu-
cleus (d, N) show no labeling for dynein. Bar, 100 nm.The Journal of Cell Biology, Volume 136, 1997 1020
tor for the transport of incoming viral capsids to the nu-
cleus. The same applies to the axons of neurons, where the
MT have their plus ends toward the synapse, and the mi-
nus end anchored at the MTOC in the cell body (Black
and Baas, 1989). Although some kinesin-like MT minus
end–directed motors have been implicated to play a role in
mitosis and meiosis, none of them has been demonstrated
to be involved in interphase transport processes (Barton
and Goldstein, 1996; Hirokawa, 1996). Since the MT-medi-
ated transport that is crucial for infection of neurons also
operates in cultured fibroblasts, its analysis will be greatly
facilitated.
It is believed that dynein attachment to vesicles and ki-
netochores requires another large multimeric complex,
called dynactin, which contains 10 different proteins (Holz-
baur and Vallee, 1994; Schroer, 1994; Vallee and Sheetz,
1996). So far, receptor molecules for dynein and dynactin
have not been identified on any cargo structures, but sev-
eral studies indicate that the activity of dynein and its
binding to cargo may be regulated by phosphorylation
(Allen, 1995; Dillman and Pfister, 1994; Lin et al., 1994;
Niclas et al., 1996). Whether the binding of dynein to
HSV-1 capsids involves dynactin or other cellular compo-
nents and whether it is regulated by phosphorylation re-
mains unclear at this point. The viral protein(s) that serve
as dynein receptors also remain to be identified. Since the
polypeptide composition of the capsids and tegument is
known, some potential candidates can, however, be sin-
gled out. The capsid itself contains six different proteins.
Of these, only VP5 is known to be located at the pentons
(Trus et al., 1992), which were the sites of preferential at-
tachment of proteinaceous material onto cytosolic capsids
shown here. In addition to the bona fide capsid polypep-
tides, components derived from the tegument are also
likely to be present. For example, VP1-2, a 270-kD pro-
tein, is particularly tightly associated with the capsids
(Roizman and Furlong, 1974) and may constitute part of
the material seen attached to the pentons in our electron
micrographs. Taking advantage of the relative simplicity
of the capsids, of existing virus mutants, and of the com-
plete genomic sequence of the virus, work is in progress to
identify and to characterize the dynein receptor in HSV-1
capsids.
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